A detailed history of Covestor LTD transactions in Evolus, Inc. stock. As of the latest transaction made, Covestor LTD holds 26 shares of EOLS stock, worth $437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Previous 26 -0.0%
Holding current value
$437
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$10.45 - $13.76 $10 - $13
1 Added 4.0%
26 $0
Q1 2024

May 10, 2024

BUY
$9.99 - $14.91 $249 - $372
25 New
25 $0
Q4 2023

Feb 09, 2024

BUY
$7.6 - $10.53 $0 - $0
0 New
0 $0
Q3 2023

Nov 13, 2023

BUY
$7.15 - $10.2 $0 - $0
0 New
0 $0

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $943M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.